value of the cost per QALY gained is $5,000. If the target population was all 12-year-olds, the annualized present value of the cost per QALY gained is $3,000. Using committee assumptions of less-than-ideal utilization and including time and monetary costs until a vaccine program is implemented, the annualized present value of the cost per QALY gained is $7,400. If the target population was all 12-year-olds (assuming 50% utilization), the annualized present value of the cost per QALY gained is $4,000.
Bhandari BN, Wright TL. Hepatitis C: An Overview. Annual Review of Medicine 1995; 46:309–317.
Lemon SM, Brown EA. Hepatitis C Virus. In: Principles and Practice of Infectious Diseases. GL Mandell, JE Bennett, Dolin R eds. New York, NY: Churchill Livingstone, 1995, pp. 1474–1486.
The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Appendix 8: Hepatitis C ."
Vaccines for the 21st Century: A Tool for Decisionmaking . Washington, DC: The National Academies Press,
Please select a format:
As of 2013, the National Science Education Standards have been replaced by the Next Generation Science Standards (NGSS), available as a print book, free PDF download, and online with our OpenBook platform.
The NGSS offer a detailed description of the key scientific ideas and practices that all students should learn by the time they graduate from high school. The standards are based largely on the 2011 National Research Council report A Framework for K-12 Science Education: Practices, Crosscutting Concepts, and Core Ideas.